Optimizing Diagnostic and Therapeutic Paradigms for NRG1 Fusion-Positive Pulmonary and Gastrointestinal Malignancies
Teresa Macarulla, MD, PhD, and Cindy Neuzillet, MD, PhD, review recent data and discuss the evolving diagnostic and treatment paradigms for patients with NRG1 fusion–positive malignancies.
Expert Perspectives in Testing and Targeted Therapy: Managing Patients with EGFR Exon20+ NSCLC
Expert oncologists discuss key updates on the treatment of patients with Exon20+ non-small cell lung cancer and consider how they may be applied to clinical practice.
Transforming Transplant-Ineligible Newly Diagnosed Multiple Myeloma: From Real-World Evidence to Clinical Practice
Joselle Cook, M.B.B.S and Matthew James Pianko, MD review the latest updates concerning transplant-ineligible newly diagnosed multiple myeloma (NDMM) and provide insights on the real-world application of clinical data to improve patient outcomes.
Transforming Transplant-Eligible Newly Diagnosed Multiple Myeloma: From Real-World Evidence to Clinical Practice
Luciano Costa, MD, PhD and Timothy Schmidt, MD discuss key data updates and share pearls for community oncologists concerning transplant-eligible newly diagnosed multiple myeloma (NDMM).
Recent Advances in the Treatment of Clear Cell and Non-Clear Cell Renal Cell Carcinoma
Following updates from the 2022 IKCS meeting, experts in the field of oncology work together to review key clinical data and current treatment strategies in the setting of renal cell carcinoma.
Recent Advances in Multiple Myeloma: Applying Real-World Evidence to Clinical Practice
In a new program from CancerNetwork®, experts discuss key data updates in multiple myeloma from ASCO 2022 based on real-world evidence and how they can be applied into clinical practice.
2 Clarke Drive Cranbury, NJ 08512